Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis
Patrik Nasr, Axel Wester, Mattias Ekstedt et al. · Clinical Gastroenterology and Hepatology · 2024
BACKGROUND & AIMS: Alcohol overconsumption is a risk factor for disease progression in patients with presumed metabolic dysfunction-associated steatotic liver disease (MASLD). How commonly this occurs and how it affects progression to major adverse liver outcomes (MALOs) is not well known. METHODS: We did a register-based cohort study, including all patients with a diagnosis of MASLD in Sweden between 1987 and 2020. Patients were stratified on co-occurrence of diagnoses of alcohol-related liver disease (ALD) or alcohol use disorder (AUD) prior to MASLD diagnosis. Incident MALOs were derived from national registers. Cox regression was used to calculate hazard ratios (HRs) for incident MALO. RESULTS: A total of 15,107 patients with MASLD were identified. The median age was 55 years, and 52% were female. Of the patients, 1843 (12%) had a prior diagnosis of ALD or AUD. During follow-up, a further 787 patients (5.2%) received a diagnosis of ALD or AUD. Patients with previous ALD or AUD diagnoses at or before baseline had considerably higher rates of MALOs compared with patients without (19.5% vs 7.8%; adjusted HR, 3.12; 95% confidence interval, 2.74-3.55). Acquiring an ALD or AUD diagnosis after MASLD diagnosis was associated with higher rates of MALOs (adjusted HR, 5.81; 95% confidence interval, 4.90-6.88). CONCLUSIONS: ALD or AUD is commonly diagnosed prior to or after MASLD diagnosis. Such patients have considerably higher rates of progression to MALOs. Correctly separating between MASLD and ALD is vital to assess prognosis.
Cited by 80 works. doi:10.1016/j.cgh.2024.01.006 Open-access PDF
Authors
- Patrik Nasr
- Axel Wester
- Mattias Ekstedt
- Rickard Strandberg
- Stergios Kechagias
- Ying Shang
- Linnea Widman
- Hannes Hagström
References
- External review and validation of the Swedish national inpatient register
- The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research
- Introduction to the Analysis of Survival Data in the Presence of Competing Risks
- A multisociety Delphi consensus statement on new fatty liver disease nomenclature
- Registers of the Swedish total population and their use in medical research
- The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
- Global burden of alcoholic liver diseases
- A multisociety Delphi consensus statement on new fatty liver disease nomenclature
- Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
- Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study